Render Target: SSR
Render Timestamp: 2024-11-29T15:58:04.603Z
Commit: cd2fae6ca3f811b1ddb1df24ac291ed56d5d501b
XML generation date: 2024-09-30 01:59:35.441
Product last modified at: 2024-11-06T17:00:10.887Z
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

MYH7 (E3G8Q) Rabbit mAb #64038

Filter:
  • WB

    Supporting Data

    REACTIVITY H R
    SENSITIVITY Endogenous
    MW (kDa) 140-210
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    Species Cross-Reactivity Key:
    • H-Human 
    • R-Rat 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    MYH7 (E3G8Q) Rabbit mAb recognizes endogenous levels of total MYH7 protein.

    Species Reactivity:

    Human, Rat

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu1932 of human MYH7 protein.

    Background

    Myosin heavy chain 7 (MYH7), also known as β-myosin heavy chain, is a type I slow-twitch fiber expressed in muscle fibers as well as heart ventricles and is essential for muscle contraction (1). MYH7 is composed of a globular head domain at the N-terminus, a hinge region, and an α-helical coil-coil rod domain (2). MYH7 forms a hexameric complex with two MYH7, two myosin light chain 2 (MYL2), and two myosin light chain 3 (MYL3) (3). The myosin-binding sites on actin filaments become exposed by the binding of Ca+, which leads to actin-myosin junction formation and the ability to glide along the actin base. The complexes become detached in the presence of ATP, and the next cycle of contraction is initiated when ATPase activity of the head domain hydrolyzes ATP (4). Mutations in the MYH7 gene can lead to hypertrophic cardiomyopathy (HCM), dilated CM (DCM), and left ventricle non-compaction (LVNC) (5).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.